Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Emeryville, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Kyverna Therapeutics, Inc. has filed 182 SEC EDGAR filings since 05 Oct 2023

SEC filing history

Showing 26-50 of 182 matching filings.

Per page
25
Current page
2
144 File 001-41947

144 filing

Filing date
07 Apr 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-294645

EFFECT filing

Filing date
02 Apr 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-294645

424B5

Filing date
02 Apr 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-41947

144 filing

Filing date
31 Mar 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
31 Mar 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD File 333-294645

UPLOAD filing

Filing date
30 Mar 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
17 Mar 2026
Reporting date
13 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
17 Mar 2026
Reporting date
13 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
17 Mar 2026
Reporting date
13 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3

Filing date
04 Mar 2026
Reporting date
24 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
04 Mar 2026
Reporting date
24 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
26 Feb 2026
Reporting date
24 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3

Filing date
26 Feb 2026
Reporting date
24 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-94441

SCHEDULE 13G/A filing

Filing date
17 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-94441

SCHEDULE 13G/A filing

Filing date
17 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3

Filing date
11 Feb 2026
Reporting date
09 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
11 Feb 2026
Reporting date
09 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-94441

SCHEDULE 13G/A filing

Filing date
06 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
14 Jan 2026
Reporting date
12 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .